Actively Recruiting
Determining the MCID for the TOPICS-SF and PROMIS-10 in Older Patients That Suffered an Ischemic Stroke or TIA
Led by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated on 2024-12-04
125
Participants Needed
2
Research Sites
32 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patient-related outcome measures (PROMs) play a crucial role in assessing patient outcomes in healthcare. Two of these PROMs are the The Older Persons and Informal Caregivers Survey Short Form (TOPICS-SF) and Patient-Reported Outcomes Measurement Information System Global Health Short Form (PROMIS-10). The investigators aim to determine the Minimal Clinically Important Difference (MCID) for the TOPICS-SF and PROMIS-10 in older people that suffered an ischemic stroke or Transient Ischemic Attack (TIA), using an anchor-based method.
CONDITIONS
Official Title
Determining the MCID for the TOPICS-SF and PROMIS-10 in Older Patients That Suffered an Ischemic Stroke or TIA
Who Can Participate
Eligibility Criteria
You may qualify if you...
- age = 70 years or older at the time of ischemic stroke or TIA;
- inclusion within a week after diagnosis of ischemic stroke or TIA
You will not qualify if you...
- not speaking Dutch;
- being unable to answer questions;
- being unable or not willing to give written informed consent.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
OLVG, locatie West
Amsterdam, North Holland, Netherlands, 1061 AE
Not Yet Recruiting
2
Amsterdam UMC, locatie AMC
Amsterdam, North Holland, Netherlands, 1105AZ
Actively Recruiting
Research Team
S
Susanna R Prins, MSc
CONTACT
B
Birgit A Damoiseaux-Volman,, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here